Search
Displaying results 571 - 580 of 10000 in total
4-Flourobenzenesulfonamide
go.drugbank.com/drugs/DB01784ExperimentalSynonyms: 4-Flourobenzenesulfonamide4-methoxybenzenesulfinate
go.drugbank.com/drugs/DB03033ExperimentalSynonyms: 1-methyloxy-4-sulfone-benzene, 4-methoxybenzenesulfinate4-hydroxycoumarin
go.drugbank.com/drugs/DB03410ExperimentalSynonyms: 4-hydroxy-2-chromenone, 4-hydroxy-2H-1-benzopyran-2-oneCategories: Vitamin K Antagonists, Heterocyclic Compounds, 1-Ring4-Vinylguaiacol
go.drugbank.com/drugs/DB03514ExperimentalSynonyms: 2-(4-hydroxy-3-methoxyphenyl)ethene, 2-methoxy-4-vinylphenolCoptisine
go.drugbank.com/drugs/DB19308ExperimentalSynonyms: 6,7-dihydrobis(1,3)benzodioxolo(5,6-a:4',5'-g)quinolizinium, Bis(1,3)benzodioxolo(5,6-a:4',5'-g)quinolizinium, 6,7-dihydro-Categories: Heterocyclic Compounds with 4 or More RingsA Disubstituted Succinyl Caprolactam Hydroxymate Mmp3inhibitor
go.drugbank.com/drugs/DB02090ExperimentalSynonyms: A Disubstituted Succinyl Caprolactam Hydroxymate Mmp3inhibitor1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE
go.drugbank.com/drugs/DB07435ExperimentalSynonyms: 1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENELoncastuximab tesirine
go.drugbank.com/drugs/DB16222ApprovedInvestigationalRelapsed and refractory B-cell acute lymphoblastic leukemia (B-ALL) are a therapeutic challenge for patients who have undergone prior systemic therapies with limited success. … [L45206] This therapy was developed by ADC Therapeutics and its accelerated approval for relapsed or refractory B-cell lymphoma is based on promising results from the LOTIS-2 clinical trial.
Synonyms: Humanized monoclonal immunoglobulin G1 antibody directed against human CD19 conjugated to SG3199 through A protease cleavable valine-alanine linkerCategories: P-glycoprotein substrates, Cytochrome P-450 Substrates